22488764Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJHepatology (Baltimore, Md.)Fatty LiverHumans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Metformin; Non-alcoholic Fatty Liver Disease; Prevalence; Risk Factors; Thiazolidinediones; Vitamin EThe diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012 Jun; 55(6):2005-23.Hepatology2012-06-01T00:00:002012The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMichaelCharltonMichael Charlton0.000000000000000.000000000000003423Charlton, MichaelProfessorAuthorship 10158970.1101490.1101491authors10.2510has subject areaD005234Disorders451240.890189Fatty LiverMedicine-GastroenterologyD008687Chemicals & Drugs621280.857521MetforminD012307Concepts & Ideas94153970.464257Risk FactorsD006801Living Beings2262862810.130064HumansD014810Chemicals & Drugs23350.984286Vitamin ED015995Concepts & Ideas48312390.726646PrevalenceD019161Chemicals & Drugs893780.727265Hydroxymethylglutaryl-CoA Reductase InhibitorsD045162Chemicals & Drugs41820.945628ThiazolidinedionesD065626Disorders362100.759746Non-alcoholic Fatty Liver DiseaseD008019Activities & BehaviorsDisorders991880.906536Life StyleUniversity of Chicagotrue1ProfessorProfessor